Cuihua Lu

2.5k total citations
99 papers, 1.8k citations indexed

About

Cuihua Lu is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Cuihua Lu has authored 99 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 28 papers in Oncology and 23 papers in Epidemiology. Recurrent topics in Cuihua Lu's work include Liver Disease Diagnosis and Treatment (18 papers), Ubiquitin and proteasome pathways (13 papers) and RNA modifications and cancer (13 papers). Cuihua Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Ubiquitin and proteasome pathways (13 papers) and RNA modifications and cancer (13 papers). Cuihua Lu collaborates with scholars based in China and Saudi Arabia. Cuihua Lu's co-authors include Runzhou Ni, Mingbing Xiao, Feng Jiang, Wenkai Ni, Jinxia Liu, Lishuai Qu, Song He, Jing Zhu, Lili Yu and Buyou Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Agricultural and Food Chemistry.

In The Last Decade

Cuihua Lu

94 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cuihua Lu China 25 1.2k 512 306 295 257 99 1.8k
Keiichi Tamai Japan 24 1.3k 1.1× 916 1.8× 355 1.2× 421 1.4× 260 1.0× 63 2.2k
Mihai Gagea United States 27 1.6k 1.4× 784 1.5× 506 1.7× 208 0.7× 363 1.4× 62 2.4k
Yufeng Xiao China 26 1.5k 1.3× 1.0k 2.0× 292 1.0× 247 0.8× 149 0.6× 49 2.1k
Neşe Atabey Türkiye 21 819 0.7× 328 0.6× 293 1.0× 158 0.5× 106 0.4× 60 1.6k
Tetyana Yevsa Germany 14 860 0.7× 390 0.8× 580 1.9× 212 0.7× 696 2.7× 25 2.0k
He‐Xin Yan China 26 1.4k 1.2× 644 1.3× 631 2.1× 366 1.2× 387 1.5× 53 2.6k
Yongyu Shi China 29 1.3k 1.1× 379 0.7× 624 2.0× 358 1.2× 868 3.4× 65 2.5k
Ji‐Liang Li China 17 914 0.8× 609 1.2× 291 1.0× 204 0.7× 173 0.7× 41 1.6k

Countries citing papers authored by Cuihua Lu

Since Specialization
Citations

This map shows the geographic impact of Cuihua Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuihua Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuihua Lu more than expected).

Fields of papers citing papers by Cuihua Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuihua Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuihua Lu. The network helps show where Cuihua Lu may publish in the future.

Co-authorship network of co-authors of Cuihua Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Cuihua Lu. A scholar is included among the top collaborators of Cuihua Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuihua Lu. Cuihua Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jing, et al.. (2025). Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis. Frontiers in Oncology. 14. 1483196–1483196. 2 indexed citations
2.
Zhang, Lu, Wei Huang, Min Li, et al.. (2025). Genetic Analyses Identify Human Serum Metabolites Associated With Risk of Gastroesophageal Reflux Disease: A Mendelian Randomization Study. British Journal of Hospital Medicine. 86(7). 1–19.
3.
4.
Liu, Zhaoxiu, et al.. (2025). Auricularia auriculaPolysaccharides Exert Anti-inflammatory Effects in Hepatic Fibrosis by the Gut–Liver Axis and Enhancing SCFA Metabolism. Journal of Agricultural and Food Chemistry. 73(8). 4617–4629. 3 indexed citations
5.
Zhang, Lu, et al.. (2024). Targeting CFTR restoring aggrephagy to suppress HSC activation and alleviate liver fibrosis. International Immunopharmacology. 145. 113754–113754. 1 indexed citations
6.
7.
Yu, Yang, et al.. (2024). Roles of Probiotics, Prebiotics, and Postbiotics in B-Cell-Mediated Immune Regulation. Journal of Nutrition. 155(1). 37–51. 8 indexed citations
8.
9.
Xu, Wenping, Jinpei Liu, Shuqing Liu, et al.. (2023). A BBS4 mutation causes autosomal dominant polycystic liver disease. Genes & Diseases. 11(1). 72–75. 1 indexed citations
10.
Chen, Yuyan, Zhengyi Zhu, Lu Zhang, et al.. (2023). TP53 mutation‐related senescence is an indicator of hepatocellular carcinoma patient outcomes from multiomics profiles. SHILAP Revista de lepidopterología. 2(2). e20230005–e20230005. 1 indexed citations
11.
Huang, Hua, Wei Huang, Ran Ji, et al.. (2022). PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 8 indexed citations
12.
Ji, Ran, Danhua Zhou, Zhaoxiu Liu, et al.. (2021). MicroRNA-92b-3p promotes the progression of liver fibrosis by targeting CREB3L2 through the JAK/STAT signaling pathway. Pathology - Research and Practice. 219. 153367–153367. 7 indexed citations
13.
Liu, Jinxia, Lishuai Qu, Chunhua Wan, et al.. (2020). A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma. Oncogenesis. 9(9). 84–84. 26 indexed citations
14.
Zhang, Wei, Jingxin Zhang, Shiqing Zhang, et al.. (2020). Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance. Cancer Cell International. 20(1). 28–28. 33 indexed citations
15.
Zhang, Susu, Jinxia Liu, Jing Zhu, et al.. (2019). Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis. Japanese Journal of Clinical Oncology. 49(7). 646–655. 12 indexed citations
16.
Xiao, Mingbing, Dandan Jin, Wenkai Ni, et al.. (2018). β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway. Molecular Biology Reports. 45(6). 1863–1871. 18 indexed citations
17.
Liu, Jinxia, Hui Xu, Xuening Zhang, et al.. (2018). ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma. Pathology - Research and Practice. 214(9). 1356–1361. 6 indexed citations
18.
Ni, Wenkai, Buyou Chen, Cuihua Lu, et al.. (2013). Overexpressed nuclear BAG‐1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin. Journal of Cellular Biochemistry. 114(9). 2120–2130. 19 indexed citations
19.
Ni, Runzhou, Qingchun Deng, Xiaodong Huang, et al.. (2013). Glyoxylate Reductase/Hydroxypyruvate Reductase: A Novel Prognostic Marker for Hepatocellular Carcinoma Patients after Curative Resection. Pathobiology. 80(3). 155–162. 8 indexed citations
20.
Zhu, Hong, Cuihua Lu, Zhen Kang, et al.. (2012). Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals. Journal of Dairy Science. 95(9). 4813–4822. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichi Tamai Breakdown of academic impact, for papers by Mihai Gagea Breakdown of academic impact, for papers by Yufeng Xiao Breakdown of academic impact, for papers by Neşe Atabey Breakdown of academic impact, for papers by Tetyana Yevsa Breakdown of academic impact, for papers by He‐Xin Yan Breakdown of academic impact, for papers by Yongyu Shi Breakdown of academic impact, for papers by Ji‐Liang Li
Rankless by CCL
2026